- Home
- POAI vs ISPC Comparison
POAI vs ISPC Comparison
Compare POAI & ISPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- POAI
- ISPC
- Stock Information
- Founded
- POAI 2002
- ISPC 2009
- Country
- POAI United States
- ISPC United States
- Employees
- POAI N/A
- ISPC N/A
- Industry
- POAI Industrial Specialties
- ISPC Precision Instruments
- Sector
- POAI Health Care
- ISPC Health Care
- Exchange
- POAI Nasdaq
- ISPC Nasdaq
- Market Cap
- POAI 6.5M
- ISPC 6.9M
- IPO Year
- POAI N/A
- ISPC 2021
- Fundamental
- Price
- POAI $6.18
- ISPC $0.65
- Analyst Decision
- POAI Hold
- ISPC
- Analyst Count
- POAI 1
- ISPC 0
- Target Price
- POAI N/A
- ISPC N/A
- AVG Volume (30 Days)
- POAI 44.5K
- ISPC 348.0K
- Earning Date
- POAI 11-14-2025
- ISPC 11-14-2025
- Dividend Yield
- POAI N/A
- ISPC N/A
- EPS Growth
- POAI N/A
- ISPC N/A
- EPS
- POAI N/A
- ISPC N/A
- Revenue
- POAI $1,664,696.00
- ISPC $5,908,088.00
- Revenue This Year
- POAI $486.27
- ISPC $35.93
- Revenue Next Year
- POAI $65.50
- ISPC N/A
- P/E Ratio
- POAI N/A
- ISPC N/A
- Revenue Growth
- POAI 71.65
- ISPC N/A
- 52 Week Low
- POAI $4.76
- ISPC $0.55
- 52 Week High
- POAI $45.90
- ISPC $5.14
- Technical
- Relative Strength Index (RSI)
- POAI 36.97
- ISPC 35.66
- Support Level
- POAI $8.05
- ISPC $0.75
- Resistance Level
- POAI $9.47
- ISPC $0.82
- Average True Range (ATR)
- POAI 0.94
- ISPC 0.07
- MACD
- POAI -0.64
- ISPC -0.00
- Stochastic Oscillator
- POAI 26.61
- ISPC 27.96
About POAI Predictive Oncology Inc.
Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.
About ISPC iSpecimen Inc.
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research, with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas; Europe, the Middle East, Africa, and Asia Pacific, which majority, comes from the Americas.